Jazz Pharma nears deal to buy Celator for about $1.5 bln -WSJ
May 30, 2016 at 23:56 PM EDT
May 30 (Reuters) - Ireland-based Jazz Pharmaceuticals Plc is nearing a deal to buy Celator Pharmaceuticals Inc for about $1.5 billion, the Wall Street Journal reported.
